Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Current Ratio
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abbott Laboratories, current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


The current ratio exhibited considerable fluctuation between 2005 and 2025. Initially, the ratio stood at 1.54 in 2005, decreased significantly to 0.94 in 2006, and then recovered to 1.54 in 2007. Subsequent years showed moderate variability before a substantial increase in 2012, peaking at 2.36. Following this peak, the ratio generally trended downwards, reaching a low of 1.44 in 2018, before stabilizing and showing a slight upward trend towards 1.58 in 2025.

Overall Trend
The period under review demonstrates a lack of consistent directional movement. While the ratio generally remained above 1.0, indicating sufficient current assets to cover current liabilities, the volatility suggests changes in working capital management or short-term financial strategies. The most pronounced shift occurred between 2011 and 2013, with a significant increase in the ratio.
Early Period (2005-2009)
The initial five-year period showed a marked decline in 2006, potentially indicating increased short-term obligations or a decrease in liquid assets. The subsequent recovery in 2007 and the relatively stable values through 2009 suggest a correction of this imbalance. The ratio increased to 1.79 in 2009, representing a healthy short-term financial position.
Mid-Period (2010-2014)
From 2010 to 2014, the current ratio experienced a decline, falling from 1.29 to 1.45. This suggests a potential increase in current liabilities relative to current assets. However, the ratio remained above 1.0 throughout this period, indicating continued short-term solvency. The decrease in 2013 and 2014 may warrant further investigation into the composition of current assets and liabilities.
Later Period (2015-2025)
The period from 2015 to 2025 was characterized by significant fluctuations. A substantial increase to 4.02 was observed in 2015, followed by a decline to 1.67 in 2016. The ratio then stabilized in the 1.6 to 1.8 range for the remainder of the period, with a slight decrease to 1.58 in 2025. This suggests a period of adjustment following the unusually high ratio in 2015, and a return to a more typical level of liquidity.

In conclusion, the current ratio demonstrates a dynamic pattern over the analyzed timeframe. While generally maintaining a value above 1.0, the observed volatility suggests the company’s short-term liquidity position was subject to periodic shifts, potentially influenced by operational changes or financing decisions.


Comparison to Competitors

Abbott Laboratories, current ratio, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Abbott Laboratories, current ratio, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)